Methotrexate Discontinuation and Dose Decreases After Therapy With Tocilizumab: Results From the Corrona Rheumatoid Arthritis Registry

INTRODUCTION: Similar outcomes have been observed between patients with rheumatoid arthritis (RA) responding to tocilizumab (TCZ) with methotrexate (MTX) who discontinued vs. continued MTX and between patients receiving MTX who added TCZ vs. switched to TCZ monotherapy. This study examined MTX disco...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Rheumatol Ther
Päätekijät: Pappas, Dimitrios A., Blachley, Taylor, Zlotnick, Steve, Best, Jennie, Emeanuru, Kelechi, Kremer, Joel M.
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Springer Healthcare 2020
Aiheet:
Original Research
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC7211217/
https://ncbi.nlm.nih.gov/pubmed/32232740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40744-020-00200-z
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia